Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085631 (
agitation
)
12,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report
FK506
-induced neurotoxicity in 14 of 44 consecutive patients following orthoptic liver transplantation. In 10 of these 14 patients, postural hand tremors were found in the first weeks following surgery, transient apraxia of speech in 3, and generalized tonic-clonic seizures were noted in 2 patients. Other manifestations included nightmares,
agitation
, and acute delirium. Reduction of the
FK506
dose resulted in resolution of symptoms, but in 1 patient mild speech difficulties and in 3 patients a fine tremor remained. Blood and plasma levels of
FK506
were similar in patients with and without neurotoxicity.
FK506
neurotoxicity in patients with liver transplantation commonly results in transient neurological manifestations. The incidence of neurotoxicity in
FK506
is dramatically reduced in maintenance doses of 0.075 mg/kg twice a day.
...
PMID:FK506-induced neurotoxicity in liver transplantation. 751 20
Tacrolimus (
FK506
), an immunosuppressant, has been associated with mutism in adults after liver transplant. Speech arrest,
agitation
, tremor, ataxia, and downward gaze deviation in a 5-year-old female 13 days after orthotopic liver transplant are reported.
FK506
, which began to be administered 12 days earlier, rose to a level of 44 ng/mL (normal range, 10-20 ng/mL) 1 day before neurologic abnormalities began.
FK506
dose level was maintained and then reduced. Three days later the patient could say a few single words and extra-ocular movement returned to normal. Four months later, she continued to exhibit decreased fluency and dysarthria with ataxia. One year later, decreased fluency and mild ataxia persists. Rapid identification of speech loss linked to
FK506
may be important because reduction or cessation of the drug may be associated with reverse of speech loss.
...
PMID:Tacrolimus (FK506)-induced mutism after liver transplant. 1269 71